Global Longlife Hospital And Research Ltd vs Max Healthcare Institute Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Nov 01, 2026

Key Highlights

The Latest Trading Price of Global Longlife Hospital and Research Ltd is ₹ 12.82 as of 30 Oct 15:30 . The P/E Ratio of Global Longlife Hospital and Research Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe P/E Ratio of Max Healthcare Institute Ltd changed from 55.6 on March 2022 to 64.9 on March 2026 . This represents a CAGR of 3.14% over 5 years The Market Cap of Global Longlife Hospital and Research Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Market Cap of Max Healthcare Institute Ltd changed from ₹ 19903 crore on March 2021 to ₹ 93581 crore on March 2026 . This represents a CAGR of 29.43% over 6 years The revenue of Global Longlife Hospital and Research Ltd for the Sep '26 is ₹ 0 crore as compare to the Jun '26 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Max Healthcare Institute Ltd for the Sep '26 is ₹ 2610 crore as compare to the Jun '26 revenue of ₹ 2406 crore. This represent the growth of 8.45% The ebitda of Global Longlife Hospital and Research Ltd for the Sep '26 is ₹ 0 crore as compare to the Jun '26 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Max Healthcare Institute Ltd for the Sep '26 is ₹ 752.39 crore as compare to the Jun '26 ebitda of ₹ 638.97 crore. This represent the growth of 17.75% The net profit of Global Longlife Hospital and Research Ltd changed from ₹ 0 crore to ₹ 0 crore over 10 quarters. This represents a CAGR of 0.0% The net profit of Max Healthcare Institute Ltd changed from ₹ 236.27 crore to ₹ 414.45 crore over 10 quarters. This represents a CAGR of 25.21% The Dividend Payout of Global Longlife Hospital and Research Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Max Healthcare Institute Ltd changed from 13.98 % on March 2023 to 27.16 % on March 2026 . This represents a CAGR of 18.06% over 4 years .

About Global Longlife Hospital and Research Ltd

Global Longlife Hospital and Research Limited was originally incorporated as 'Global Longlife Hospital and Research Private Limited' on January 20, 2012 with Registrar of Companies, Gujarat.
Subsequently, Company was converted into a Public Limited Company and , name of the Company was changed to 'Global Longlife Hospital and Research Limited' vide fresh Certificate of Incorporation dated August 31, 2021. The Company had acquired 1339 sq.mt. area land in the prime locality of Ahmedabad for starting hospital in March 2012.
The Hospital started journey in 2015 & determined to build an institution that offer to every human being, high quality healthcare at affordable prices in Ahmedabad. Mr. Dhruv Jani had also joined the hospital business with his father in July 2015.
The majority Equity shares of the Company were taken over by the present Promoters by acquiring the Equity shares from the Doctors and investors in the year 2017.

About Max Healthcare Institute Ltd

Max Healthcare Institute Limited was originally incorporated as 'Infinitum Technologies Private Limited' at New Delhi, India as a Private Limited Company dated June 18 ,2001.
Pursuant to a Fresh Certificate of Incorporation dated June 28, 2002, the name of Infinitum Technologies Private Limited' was changed to Max Healthcare Institute Private Limited'.
Thereafter, pursuant to a Special Resolution dated May 16, 2002 and a fresh Certificate of Incorporation dated October 18, 2002, the Company converted to a Public Limited, and name was changed to Max Healthcare Institute Limited'.
The Company is primarily engaged in provision of healthcare services through primary care clinics, multi speciality hospitals / medical centres and superspecialty Hospitals facilities. The Company is a leading hospital chains in India with major concentration in North India consisting of a network of 22 network healthcare facilities, which includes BLK Hospital and BNH Hospital.

FAQs for the comparison of Global Longlife Hospital and Research Ltd and Max Healthcare Institute Ltd

Which company has a larger market capitalization, Global Longlife Hospital and Research Ltd or Max Healthcare Institute Ltd?

Market cap of Global Longlife Hospital and Research Ltd is 13 Cr while Market cap of Max Healthcare Institute Ltd is 83,704 Cr

What are the key factors driving the stock performance of Global Longlife Hospital and Research Ltd and Max Healthcare Institute Ltd?

The stock performance of Global Longlife Hospital and Research Ltd and Max Healthcare Institute Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Global Longlife Hospital and Research Ltd and Max Healthcare Institute Ltd?

As of November 1, 2026, the Global Longlife Hospital and Research Ltd stock price is INR ₹12.82. On the other hand, Max Healthcare Institute Ltd stock price is INR ₹860.0.

How do dividend payouts of Global Longlife Hospital and Research Ltd and Max Healthcare Institute Ltd compare?

To compare the dividend payouts of Global Longlife Hospital and Research Ltd and Max Healthcare Institute Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.